CSI Market
Sign In | Register

Adaptive Biotechnologies (ADPT) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access ADPT Annual Balance Sheets →
Balance sheet data covering Adaptive Biotechnologies–Jun 30 2025 offers a view into how Jun 30 2026's financial position has changed alongside business activity.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Jun 30 2026)
(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Assets
Cash & cash equivalent169.87
Available-for-sale Securities, Debt Securities, Current MA174.38
Cash & Short-term Investments343.00
Accounts receivable49.51
Inventories10.50
Prepaid Expense And Other Assets Current16.30
Total Current Assets420.56
Equipment/Property/Plant Net29.45
Goodwill net118.97
Intangible Assets0.88
Long-term investments27.48
Other Assets, Noncurrent43.33
Restricted Cash Noncurrent2.71
Total Assets640.68
Liabilities
Accounts Payable, Current AC5.24
Accrued Liabilities, Current10.65
Long-term Debt, Current Maturities LO0.00
Other Liabilities, Current71.82
Total Current Liabilities87.71
Long-term debt0.00
Total Long-term Debt0.00
Other liabilities, Noncurrent402.30
Contract With Customer Liability Current49.40
Contract With Customer Liability Noncurrent0.81
Total Liabilities490.02
Stockholders' Equity
Common Stock Value0.02
Additional Paid In Capital Common Stock1,566.25
Retained Earnings / Accumulated Deficit-1,423.14
Accumulated Other Comprehensive Income-0.21
Other Equity-0.21
Common Stockholder's Equity142.91
Non-controlling interests & other7.75
Total Stockholder's Equity150.66
Liabilities & Stockholder's Equity640.68
4 historic quarters locked

Sign in to unlock the full Adaptive Biotechnologies balance sheet history.

Sign In Create Free Account

About Adaptive Biotechnologies Corp Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001193125-26-332940

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.